These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 6337307)
1. Laboratory tests used to guide antimicrobial therapy. Rosenblatt JE Mayo Clin Proc; 1983 Jan; 58(1):14-20. PubMed ID: 6337307 [TBL] [Abstract][Full Text] [Related]
2. Laboratory tests used to guide antimicrobial therapy. Rosenblatt JE Mayo Clin Proc; 1977 Oct; 52(10):611-5. PubMed ID: 333194 [TBL] [Abstract][Full Text] [Related]
3. Laboratory tests used to guide antimicrobial therapy. Rosenblatt JE Mayo Clin Proc; 1987 Sep; 62(9):799-805. PubMed ID: 3626629 [TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility tests and their role in therapeutic drug monitoring. DeGirolami PC; Eliopoulos G Clin Lab Med; 1987 Sep; 7(3):499-512. PubMed ID: 3308291 [TBL] [Abstract][Full Text] [Related]
5. Laboratory tests used to guide antimicrobial therapy. Rosenblatt JE Mayo Clin Proc; 1991 Sep; 66(9):942-8. PubMed ID: 1921504 [TBL] [Abstract][Full Text] [Related]
6. Available laboratory tests to guide antimicrobial therapy. Araj GF J Med Liban; 2000; 48(4):199-202. PubMed ID: 11214189 [TBL] [Abstract][Full Text] [Related]
7. Laboratory support for choosing and monitoring antimicrobial therapy in severely ill patients. Zinner SH; Blaser J; Gaya H Am J Med; 1986 May; 80(5C):59-63. PubMed ID: 3717189 [TBL] [Abstract][Full Text] [Related]
9. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance. Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955 [TBL] [Abstract][Full Text] [Related]
10. Concept of empiric therapy with antibiotic combinations. Indications and limits. Klastersky J Am J Med; 1986 May; 80(5C):2-12. PubMed ID: 3521271 [TBL] [Abstract][Full Text] [Related]
11. [Quantitative sensitivity determination of bacteria. Indications and methods]. von Graevenitz A; Heitz M; Lüthy R; Meyer J; Tosch W Schweiz Med Wochenschr; 1987 Apr; 117(14):509-17. PubMed ID: 3554500 [TBL] [Abstract][Full Text] [Related]
12. [Antimicrobial susceptibility testing of bacteria isolated from animals: methods for in-vitro susceptibility testing and their suitability with regard to the generation of the most useful data for therapeutic applications]. Schwarz S; Böttner A; Hafez HM; Kehrenberg C; Kietzmann M; Klarmann D; Klein G; Krabisch P; Kühn T; Luhofer G; Richter A; Traeder W; Waldmann KH; Wallmann J; Werckenthin C Berl Munch Tierarztl Wochenschr; 2003; 116(9-10):353-61. PubMed ID: 14526464 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods. Moody JA; Gerding DN; Peterson LR Am J Med; 1987 Apr; 82(4A):44-54. PubMed ID: 3107380 [TBL] [Abstract][Full Text] [Related]
14. Performance and clinical significance of direct antimicrobial susceptibility testing on urine from hospitalized patients. Breteler KB; Rentenaar RJ; Verkaart G; Sturm PD Scand J Infect Dis; 2011 Oct; 43(10):771-6. PubMed ID: 21696255 [TBL] [Abstract][Full Text] [Related]
15. General principles of antimicrobial therapy. Wilkowske CJ; Hermans PE Mayo Clin Proc; 1983 Jan; 58(1):6-13. PubMed ID: 6823153 [TBL] [Abstract][Full Text] [Related]
16. General principles of antimicrobial therapy. Hermans PE Mayo Clin Proc; 1977 Oct; 52(10):603-10. PubMed ID: 20538 [TBL] [Abstract][Full Text] [Related]
17. Strategies for antimicrobial susceptibility testing of fastidious aerobic bacteria. Hindler J Am J Med Technol; 1983 Nov; 49(11):761-7. PubMed ID: 6418005 [TBL] [Abstract][Full Text] [Related]
18. In vitro testing of antimicrobial agents. Woods GL Infect Dis Clin North Am; 1995 Sep; 9(3):463-81. PubMed ID: 7490428 [TBL] [Abstract][Full Text] [Related]
19. [Determination of serum aminoglycoside and vancomycin concentrations by the microbiological method in the presence of other antimicrobials]. Corso A; Galas MF; Rossi MA Rev Argent Microbiol; 1996; 28(3):123-31. PubMed ID: 9026822 [TBL] [Abstract][Full Text] [Related]
20. Time-kill and synergism studies of ceftobiprole against Enterococcus faecalis, including beta-lactamase-producing and vancomycin-resistant isolates. Arias CA; Singh KV; Panesso D; Murray BE Antimicrob Agents Chemother; 2007 Jun; 51(6):2043-7. PubMed ID: 17438057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]